The portfolio of A. Menarini AG consists of medicinal products for primary patient care, i.e. products that are predominantly prescribed by general practitioners and the appropriate specialists.
The company's main focus is on the cardiovascular field with products sold for the treatment of hypertension (high blood pressure), angina pectoris (chest pain) and heart failure (cardiac insufficiency). A second main focus is on oral antidiabetic agents that belong to the class of state-of-the-art medicinal products taken orally to treat type 2 diabetes.
The range for general practitioners also comprises products from the therapeutic areas of pain management, infectiology, allergology and, most recently, urology. Further areas will be opened up in future through global partnerships with other companies.
Located in the heart of Europe (yet not tied into the EU), Menarini Switzerland is heading towards a promising future with great energy and innovation.